BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, February 13, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 6, 1998
View Archived Issues
Axcan: Annual Report 1997
Read More
ART-123, a human recombinant thrombomodulin, demonstrates acceptable safety profile
Read More
Novel HIV vaccine available for licensing from NIH
Read More
Green Cross reveals potent, selective angiotensin II antagonists
Read More
Agents for hyperlipidemia under investigation at HMR
Read More
TER-199 resistance-modulating mechanisms explored
Read More
Inhale reports successful phase I and II results with drugs from Baxter collaboration
Read More
Vaxcel acquires rights to cancer antigen
Read More
Amidino derivatives for thrombosis reported by Astra
Read More
Protein tyrosine kinase inhibitors emerge from R&D at Glaxo Wellcome
Read More
Takeda claims bicyclic compounds for micturition disorders
Read More
American Home Products synthesizes and evaluates new smooth muscle relaxants
Read More
Highly potent GH secretatogues discovered by Merck & Co.
Read More
Selective PDE IV/TNF-alpha inhibitors focus of research at Yamanouchi
Read More
Pivotal phase III trial of Nabi-StaphVAX now under way
Read More
New U.S. patent provides further protection for Onconase and related products
Read More
Orally active thrombin inhibitor discovered at Pfizer shows good tolerance in phase I
Read More
The alpha1L-adrenoceptor: a new target for BPH therapy
Read More
Norian and Shofu collaborate on new applications for Norian SRS
Read More
RS-100975, a prostate-selective alpha-blocker in vitro
Read More
Prostate cancer immunotherapeutic evaluated in preclinical and clinical trials
Read More
Leukocyte activation inhibitor active in animal models of myocardial infarction
Read More
EchoGen recommended for approval in the European Union
Read More
Antiplatelet and antithrombotic effects of FR-171113 in guinea pigs
Read More
Baxter suspends study of HemAssist in U.S. trauma patients; other trials continue
Read More
Genetronics' EPT plus bleomycin looks effective in prostate cancer
Read More
YM-905 shows promise as safe and effective treatment for overactive detrusor
Read More
YM-905 shows promising activity in animal model of IBS
Read More
